Helmut R. Mäcke

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

Human Somatostatin Receptor, Affinity Profiles, Somatostatin Radiotracers +6

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

Anna Imhof, Philippe Brunner, Nicolas Marincek et al. · Journal of Clinical Oncology · 2011 · 616 citations

Radiolabeled somatostatin receptor antagonists are preferable to agonists for<i>in vivo</i>peptide receptor targeting of tumors

Mihaela Ginj, Hanwen Zhang, Beatrice Waser et al. · Proceedings of the National Academy of Sciences · 2006 · 488 citations · Full text

Engineering, Immunology, Peptide Science +22

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy

A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke et al. · Chemistry - A European Journal · 1999 · 332 citations

Peptide Engineering, Peptide Science, Peptide Therapeutics +18

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

Lisa Bodei, Marta Cremonesi, Stefania Zoboli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 304 citations

Receptor-mediated Radionuclide Therapy, Engineering, Medicine +9